We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

1,056 hedge funds and large institutions have $96.1B invested in Allergan plc in 2015 Q3 according to their latest regulatory filings, with 121 funds opening new positions, 402 increasing their positions, 407 reducing their positions, and 93 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more first-time investments, than exits

New positions opened: 121 | Existing positions closed: 93

15% more call options, than puts

Call options by funds: $1.73B | Put options by funds: $1.51B

2% more funds holding

Funds holding: 1,0351,056 (+21)

1% less repeat investments, than reductions

Existing positions increased: 402 | Existing positions reduced: 407

7% less capital invested

Capital invested by funds: $103B → $96.1B (-$7.12B)

11% less funds holding in top 10

Funds holding in top 10: 176157 (-19)

Holders
1,056
Holders Change
+21
Holders Change %
+2.03%
% of All Funds
29.48%
Holding in Top 10
157
Holding in Top 10 Change
-19
Holding in Top 10 Change %
-10.8%
% of All Funds
4.38%
New
121
Increased
402
Reduced
407
Closed
93
Calls
$1.73B
Puts
$1.51B
Net Calls
+$223M
Net Calls Change
+$273M
Name Holding Trade Value Shares
Change
Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$850M +$963M +3,134,775 New
UBS AM
27
UBS AM
Illinois
$819M +$75.5M +245,695 +9%
Morgan Stanley
28
Morgan Stanley
New York
$774M -$45.1M -146,661 -5%
Massachusetts Financial Services
29
Massachusetts Financial Services
Massachusetts
$710M -$4.29M -13,960 -0.5%
LPC
30
Lone Pine Capital
Connecticut
$709M +$95.1M +309,689 +13%
Goldman Sachs
31
Goldman Sachs
New York
$673M +$245M +798,418 +48%
Wells Fargo
32
Wells Fargo
California
$665M +$163M +530,580 +28%
O
33
OppenheimerFunds
New York
$652M -$103M -336,755 -12%
GE
34
General Electric
Ohio
$604M -$17.8M -57,992 -3%
FAM
35
Fred Alger Management
New York
$586M -$144M -469,562 -18%
IC
36
Institutional Capital
Illinois
$578M +$95.4M +310,518 +17%
CM
37
Corvex Management
New York
$546M +$143M +464,090 +30%
DCM
38
Discovery Capital Management
Connecticut
$540M +$327M +1,065,550 +116%
AllianceBernstein
39
AllianceBernstein
Tennessee
$538M -$187M -607,695 -23%
SIG
40
Senator Investment Group
New York
$523M -$23M -75,000 -4%
JP
41
Jana Partners
New York
$513M +$82.5M +268,546 +17%
BA
42
BlackRock Advisors
Delaware
$504M +$5.64M +18,346 +1%
First Eagle Investment Management
43
First Eagle Investment Management
New York
$454M +$38.3M +124,832 +8%
BRC
44
Blue Ridge Capital
New York
$443M +$50.6M +164,842 +11%
Neuberger Berman Group
45
Neuberger Berman Group
New York
$443M -$5.82M -18,953 -1%
UBS Group
46
UBS Group
Switzerland
$419M -$17.9M -58,305 -4%
PI
47
Putnam Investments
Massachusetts
$417M -$21.2M -68,985 -4%
GCM
48
Glenview Capital Management
New York
$414M -$141M -459,100 -23%
Dimensional Fund Advisors
49
Dimensional Fund Advisors
Texas
$406M +$56.5M +183,903 +14%
Winslow Capital Management
50
Winslow Capital Management
Minnesota
$396M +$448M +1,457,807 New

AGN Hedge Fund Activity: Q3 2015 in Review

1,056 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2015, worth a combined $96.1B — down 6.9% from $103B a quarter earlier.

Buyers outnumbered sellers: 121 funds opened new AGN positions and 93 closed out — a net gain of 28 holders — while 402 added to existing stakes and 407 trimmed.

The largest buyer was Norges Bank, opening a new position worth an estimated $1.01B. The largest seller was Fidelity Investments, cutting an estimated $1.45B.

  • 1,056 institutional investors held Allergan plc (AGN) as of Q3 2015, up from 1,035 in Q2 2015.
  • Funds reported $96.1B of Allergan plc stock for Q3 2015, down 6.9% quarter-over-quarter.
  • 121 funds opened new Allergan plc positions in Q3 2015 and 93 closed out, a net change of +28 holders.
  • The largest Allergan plc buyer in Q3 2015 was Norges Bank, an estimated $1.01B added.
  • The largest Allergan plc seller in Q3 2015 was Fidelity Investments, an estimated $1.45B sold.

Based on aggregated 13F filings for Q3 2015.